biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by wesdevrieson Apr 17, 2014 3:19pm

317 Views

Post# 22464971

My reply from Rob re:query Liolios

Thank-you for your response Rob; it’s appreciated! It is with understanding that steps take time and that BTI’s hands are tied, my query was born out of frustration with Liolios…I look forward to corresponding with your internal IR person!

Regards

Wes De Vries

On Apr 17, 2014, at 11:53 AM, Rob Hutchison <rob@bioasis.ca> wrote:

Wes - I do not normally respond to inquiries at this level, but as I am in the process of bring in an internal IR person whom has not started yet (a couple of weeks) I felt I should respond. I have sent your note to Liolios for an explanation, our Liolios representative was on holidays last week and will be getting to the 2 messages he has regarding biOasis.

I have heard from a number of shareholders that they are dissatisfied over the share price as am I, but we are limited to a certain degree on this aspect; they are dissatisfied over news, the single largest complaint of all TSX.V companies, and there are many things to consider regarding news, such as the filing of Intellectual Property Patents - we've had a ver busy year with regards to IP and as soon as our Lawyers tell me we legally all buttoned up, I 've got lots to say. And last but not least, many shareholders have asked for my comment on the Stockhouse Board messages, as I have told them I don't read the postings as in many cases, they are simply wrong, misleading, draw completely false conjecture and I wonder if things get posted to simply create a desired reaction in the market, so for those reasons I simply don't read them.

As for IR, our internal Canadian person will be starting soon and posting an inquiry as you have here will be dealt by this person in a very timely manner....

I and others are shareholders of BTI; I've/we've sent and queried questions to the Liolios group, having no response from them! What is going on? Many of us are dis-satisfied...who is it that we can contact and who is in control of investor relations so that shareholder questions will receive responses within an equitable amount of time? So far Liolios does not even respond!